(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate

C71H71F3N18O4S5 — CID 158622958

IUPAC(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate
SMILESCCc1cc(F)cc2c1[nH]c1nc(Oc3nnc(C)s3)nc(C3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Sc3cnc(-c4nnc(C)o4)s3)nc(C3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Sc3cnc(C(=O)OC)s3)nc(C3C[C@H]4C[C@@H]3C[C@H]4N)c12
InChIInChI=1S/C25H24FN7OS2.C24H24FN5O2S2.C22H23FN6OS/c1-3-11-5-14(26)8-16-19-21(15-6-13-4-12(15)7-17(13)27)30-25(31-22(19)29-20(11)16)36-18-9-28-24(35-18)23-33-32-10(2)34-23;1-3-10-5-13(25)8-15-18-20(14-6-12-4-11(14)7-16(12)26)29-24(30-21(18)28-19(10)15)34-17-9-27-22(33-17)23(31)32-2;1-3-10-5-13(23)8-15-17-19(14-6-12-4-11(14)7-16(12)24)26-21(27-20(17)25-18(10)15)30-22-29-28-9(2)31-22/h5,8-9,12-13,15,17H,3-4,6-7,27H2,1-2H3,(H,29,30,31);5,8-9,11-12,14,16H,3-4,6-7,26H2,1-2H3,(H,28,29,30);5,8,11-12,14,16H,3-4,6-7,24H2,1-2H3,(H,25,26,27)/t12-,13-,15?,17-;2*11-,12-,14?,16-/m111/s1
InChIKeyHYFQRAOTEZAYLA-AECRSZCOSA-N
MW1457.80 g/mol
LogP15.27
Rot. Bonds14

About (1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate

(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate (PubChem CID 158622958) has the molecular formula C71H71F3N18O4S5 and a molecular weight of 1457.80 g/mol. Its IUPAC name is (1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate.

Molecular Properties

Compound Name(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate
PubChem CID158622958
Molecular FormulaC71H71F3N18O4S5
Molecular Weight1457.80 g/mol
Exact Mass1456.45
IUPAC Name(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate
SMILESCCc1cc(F)cc2c1[nH]c1nc(Oc3nnc(C)s3)nc(C3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Sc3cnc(-c4nnc(C)o4)s3)nc(C3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Sc3cnc(C(=O)OC)s3)nc(C3C[C@H]4C[C@@H]3C[C@H]4N)c12
InChIInChI=1S/C25H24FN7OS2.C24H24FN5O2S2.C22H23FN6OS/c1-3-11-5-14(26)8-16-19-21(15-6-13-4-12(15)7-17(13)27)30-25(31-22(19)29-20(11)16)36-18-9-28-24(35-18)23-33-32-10(2)34-23;1-3-10-5-13(25)8-15-18-20(14-6-12-4-11(14)7-16(12)26)29-24(30-21(18)28-19(10)15)34-17-9-27-22(33-17)23(31)32-2;1-3-10-5-13(23)8-15-17-19(14-6-12-4-11(14)7-16(12)24)26-21(27-20(17)25-18(10)15)30-22-29-28-9(2)31-22/h5,8-9,12-13,15,17H,3-4,6-7,27H2,1-2H3,(H,29,30,31);5,8-9,11-12,14,16H,3-4,6-7,26H2,1-2H3,(H,28,29,30);5,8,11-12,14,16H,3-4,6-7,24H2,1-2H3,(H,25,26,27)/t12-,13-,15?,17-;2*11-,12-,14?,16-/m111/s1
InChIKeyHYFQRAOTEZAYLA-AECRSZCOSA-N
XLogP15.27
TPSA328.78 Ų
H-Bond Donors6
H-Bond Acceptors24
Rotatable Bonds14
Heavy Atoms101
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001457.80
LogP ≤ 515.27
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1024

Analyze (1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate?
The IUPAC name of (1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate (CID 158622958) is (1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate.
What is the SMILES notation for (1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate?
The canonical SMILES for (1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate is CCc1cc(F)cc2c1[nH]c1nc(Oc3nnc(C)s3)nc(C3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Sc3cnc(-c4nnc(C)o4)s3)nc(C3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Sc3cnc(C(=O)OC)s3)nc(C3C[C@H]4C[C@@H]3C[C@H]4N)c12.
What is the InChIKey of (1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate?
The InChIKey is HYFQRAOTEZAYLA-AECRSZCOSA-N. The full InChI is InChI=1S/C25H24FN7OS2.C24H24FN5O2S2.C22H23FN6OS/c1-3-11-5-14(26)8-16-19-21(15-6-13-4-12(15)7-17(13)27)30-25(31-22(19)29-20(11)16)36-18-9-28-24(35-18)23-33-32-10(2)34-23;1-3-10-5-13(25)8-15-18-20(14-6-12-4-11(14)7-16(12)26)29-24(30-21(18)28-19(10)15)34-17-9-27-22(33-17)23(31)32-2;1-3-10-5-13(23)8-15-17-19(14-6-12-4-11(14)7-16(12)24)26-21(27-20(17)25-18(10)15)30-22-29-28-9(2)31-22/h5,8-9,12-13,15,17H,3-4,6-7,27H2,1-2H3,(H,29,30,31);5,8-9,11-12,14,16H,3-4,6-7,26H2,1-2H3,(H,28,29,30);5,8,11-12,14,16H,3-4,6-7,24H2,1-2H3,(H,25,26,27)/t12-,13-,15?,17-;2*11-,12-,14?,16-/m111/s1.
What are the key properties of (1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate?
(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate has a molecular weight of 1457.80 g/mol, XLogP of 15.27, 14 rotatable bonds, 6 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[[2-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-5-yl]sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;(1R,2R,4R)-5-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-thiadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]bicyclo[2.2.1]heptan-2-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate is sourced from PubChem (CID 158622958), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).